Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dihomo-gamma-linolenic acid (1 trial)
icosapent ethyl (vascepa) (1 trial)
multivitamins (1 trial)
olive (1 trial)
Sepsis (Phase 4)
Shock, Septic (Phase 4)
Toxemia (Phase 4)
Trials (2 total)
Trial APIs (4 total)